Global and China Pneumococcal Vaccine Polyvalent Market 2020 by Manufacturers, Type and Application, Forecast to 2025
Market Overview
The global Pneumococcal Vaccine Polyvalent market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Pneumococcal Vaccine Polyvalent market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Pneumococcal Vaccine Polyvalent market is split by Type and Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Breakdown by Type, Pneumococcal Vaccine Polyvalent market has been segmented into Prevnar 13, Pneumovax23, etc.
Breakdown by Application, Pneumococcal Vaccine Polyvalent has been segmented into 18 years and younger, 19 to 64 years old, 65 years and older, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Pneumococcal Vaccine Polyvalent market presented in the report. This section sheds light on the sales growth of different regional and country-level Pneumococcal Vaccine Polyvalent markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Pneumococcal Vaccine Polyvalent market.
For China, this report analyses the China market by players, Type and Application, for the period 2015-2025.
Competitive Landscape and Pneumococcal Vaccine Polyvalent Market Share Analysis
Pneumococcal Vaccine Polyvalent competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Pneumococcal Vaccine Polyvalent sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Pneumococcal Vaccine Polyvalent sales, revenue and market share for each player covered in this report.
The major players covered in Pneumococcal Vaccine Polyvalent are: Merck & Co., Pfizer, etc. Among other players domestic and global, Pneumococcal Vaccine Polyvalent market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The key market players for global Pneumococcal Vaccine Polyvalent market are listed below:
Merck & Co.
Pfizer
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa)
Market segment by Type, covers:
Prevnar 13
Pneumovax23
Market segment by Application, can be divided into
18 years and younger
19 to 64 years old
65 years and older
Table of Contents
1 Market Overview
1.1 Pneumococcal Vaccine Polyvalent Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pneumococcal Vaccine Polyvalent Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Prevnar 13
1.2.3 Pneumovax23
1.3 Market Analysis by Application
1.3.1 Overview: Global Pneumococcal Vaccine Polyvalent Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 18 years and younger
1.3.3 19 to 64 years old
1.3.4 65 years and older
1.4 Global Pneumococcal Vaccine Polyvalent Market Size and Forecast (2015-2025)
1.4.1 Global Pneumococcal Vaccine Polyvalent Revenue and Forecast (2015-2025)
1.4.2 Global Pneumococcal Vaccine Polyvalent Sales and Forecast (2015-2025)
1.5 Global Pneumococcal Vaccine Polyvalent Market Size Overview by Geography (2015-2020)
2 Manufacturers Profiles
2.1 Merck & Co.
2.1.1 Merck & Co. Details
2.1.2 Merck & Co. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck & Co. SWOT Analysis
2.1.4 Merck & Co. Product and Services
2.1.5 Merck & Co. Pneumococcal Vaccine Polyvalent Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Pfizer SWOT Analysis
2.2.4 Pfizer Product and Services
2.2.5 Pfizer Pneumococcal Vaccine Polyvalent Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Global Pneumococcal Vaccine Polyvalent Market, Company Landscape
3.1 Company Market Share Analysis: Global
3.1.1 Global Pneumococcal Vaccine Polyvalent Sales and Market Share by Manufacturer (2018-2019)
3.1.2 Global Pneumococcal Vaccine Polyvalent Revenue and Market Share by Manufacturer (2018-2019)
3.2 Company Market Share Analysis: China
3.2.1 Key Players Pneumococcal Vaccine Polyvalent Sales in China (2018-2019)
3.2.2 China Pneumococcal Vaccine Polyvalent Revenue Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Pneumococcal Vaccine Polyvalent Manufacturer Market Share in 2019
3.3.2 Top 6 Pneumococcal Vaccine Polyvalent Manufacturer Market Share in 2019
4 Market Size by Geography
4.1 Global Pneumococcal Vaccine Polyvalent Market Size by Geography (2015-2020)
4.1.1 Global Pneumococcal Vaccine Polyvalent Sales by Geography (2015-2020)
4.1.2 Global Pneumococcal Vaccine Polyvalent Revenue by Regions (2015-2020)
4.2 Global Pneumococcal Vaccine Polyvalent Market Size and Forecast by Regions (2020-2025)
4.2.1 Global Pneumococcal Vaccine Polyvalent Sales and Forecast by Regions (2020-2025)
4.2.2 Global Pneumococcal Vaccine Polyvalent Revenue and Forecast by Regions (2020-2025)
4.3 North America Pneumococcal Vaccine Polyvalent Market Size and Forecast (2015-2025)
4.4 Europe Pneumococcal Vaccine Polyvalent Market Size and Forecast (2015-2025)
4.5 Asia-Pacific Pneumococcal Vaccine Polyvalent Market Size and Forecast (2015-2025)
4.6 South America Pneumococcal Vaccine Polyvalent Market Size and Forecast (2015-2025)
4.7 Middle East and Africa Pneumococcal Vaccine Polyvalent Market Size and Forecast (2015-2025)
5 North America by Country
5.1 North America Pneumococcal Vaccine Polyvalent Market Size by Country (2015-2020)
5.1.1 North America Pneumococcal Vaccine Polyvalent Sales and Market Share by Country (2015-2020)
5.1.2 North America Pneumococcal Vaccine Polyvalent Revenue and Market Share by Country (2015-2020)
5.2 North America Pneumococcal Vaccine Polyvalent Market Size and Forecast by Country (2020-2025)
5.2.1 North America Pneumococcal Vaccine Polyvalent Sales and Forecast by Country (2020-2025)
5.2.2 North America Pneumococcal Vaccine Polyvalent Revenue and Forecast by Country (2020-2025)
5.3 United States Pneumococcal Vaccine Polyvalent Market Size and Forecast (2015-2025)
5.4 Canada Pneumococcal Vaccine Polyvalent Market Size and Forecast (2015-2025)
5.5 Mexico Pneumococcal Vaccine Polyvalent Market Size and Forecast (2015-2025)
6 Europe by Country
6.1 Europe Pneumococcal Vaccine Polyvalent Market Size by Country (2015-2020)
6.1.1 Europe Pneumococcal Vaccine Polyvalent Sales by Country (2015-2020)
6.1.2 Europe Pneumococcal Vaccine Polyvalent Revenue by Country (2015-2020)
6.2 Europe Pneumococcal Vaccine Polyvalent Market Size and Forecast by Country (2020-2025)
6.2.1 Europe Pneumococcal Vaccine Polyvalent Sales and Forecast by Country (2020-2025)
6.2.2 Europe Pneumococcal Vaccine Polyvalent Revenue and Forecast by Country (2020-2025)
6.3 Germany Pneumococcal Vaccine Polyvalent Market Size and Forecast (2015-2025)
6.4 United Kingdom Pneumococcal Vaccine Polyvalent Market Size and Forecast (2015-2025)
6.5 France Pneumococcal Vaccine Polyvalent Market Size and Forecast (2015-2025)
6.6 Russia Pneumococcal Vaccine Polyvalent Market Size and Forecast (2015-2025)
6.7 Italy Pneumococcal Vaccine Polyvalent Market Size and Forecast (2015-2025)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Pneumococcal Vaccine Polyvalent Market Size by Region (2015-2020)
7.1.1 Asia-Pacific Pneumococcal Vaccine Polyvalent Sales by Region (2015-2020)
7.1.2 Asia-Pacific Pneumococcal Vaccine Polyvalent Revenue by Region (2015-2020)
7.2 Asia-Pacific Pneumococcal Vaccine Polyvalent Market Size and Forecast by Region (2020-2025)
7.2.1 Asia-Pacific Pneumococcal Vaccine Polyvalent Sales and Forecast by Region (2020-2025)
7.2.2 Asia-Pacific Pneumococcal Vaccine Polyvalent Revenue and Forecast by Region (2020-2025)
7.3 China Pneumococcal Vaccine Polyvalent Market Size and Forecast (2015-2025)
7.4 Japan Pneumococcal Vaccine Polyvalent Market Size and Forecast (2015-2025)
7.5 Korea Pneumococcal Vaccine Polyvalent Market Size and Forecast (2015-2025)
7.6 India Pneumococcal Vaccine Polyvalent Market Size and Forecast (2015-2025)
7.7 Southeast Asia Pneumococcal Vaccine Polyvalent Market Size and Forecast (2015-2025)
7.8 Australia Pneumococcal Vaccine Polyvalent Market Size and Forecast (2015-2025)
8 South America by Country
8.1 South America Pneumococcal Vaccine Polyvalent Market Size by Country (2015-2020)
8.1.1 South America Pneumococcal Vaccine Polyvalent Sales by Country (2015-2020)
8.1.2 South America Pneumococcal Vaccine Polyvalent Revenue by Country (2015-2020)
8.2 South America Pneumococcal Vaccine Polyvalent Market Size and Forecast by Country (2020-2025)
8.2.1 South America Pneumococcal Vaccine Polyvalent Sales and Forecast by Country (2020-2025)
8.2.2 South America Pneumococcal Vaccine Polyvalent Revenue and Forecast by Country (2020-2025)
8.3 Brazil Pneumococcal Vaccine Polyvalent Market Size and Forecast (2015-2025)
8.4 Argentina Pneumococcal Vaccine Polyvalent Market Size and Forecast (2015-2025)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Pneumococcal Vaccine Polyvalent Market Size by Country (2015-2020)
9.1.1 Middle East & Africa Pneumococcal Vaccine Polyvalent Sales by Country (2015-2020)
9.1.2 Middle East & Africa Pneumococcal Vaccine Polyvalent Revenue by Country (2015-2020)
9.2 Middle East & Africa Pneumococcal Vaccine Polyvalent Market Size and Forecast by Country (2020-2025)
9.2.1 Middle East & Africa Pneumococcal Vaccine Polyvalent Sales and Forecast by Country (2020-2025)
9.2.2 Middle East & Africa Pneumococcal Vaccine Polyvalent Revenue and Forecast by Country (2020-2025)
9.3 Saudi Arabia Pneumococcal Vaccine Polyvalent Market Size and Forecast (2015-2025)
9.4 Turkey Pneumococcal Vaccine Polyvalent Market Size and Forecast (2015-2025)
9.5 Egypt Pneumococcal Vaccine Polyvalent Market Size and Forecast (2015-2025)
9.6 South Africa Pneumococcal Vaccine Polyvalent Market Size and Forecast (2015-2025)
10 Market Segment by Type
10.1 Global Pneumococcal Vaccine Polyvalent Market Size by Type (2015-2020)
10.1.1 Global Pneumococcal Vaccine Polyvalent Sales by Type (2015-2020)
10.1.2 Global Pneumococcal Vaccine Polyvalent Revenue by Type (2015-2020)
10.1.3 Global Pneumococcal Vaccine Polyvalent Price by Type (2015-2020)
10.2 Global Pneumococcal Vaccine Polyvalent Market Size and Forecast by Type (2020-2025)
10.2.1 Global Pneumococcal Vaccine Polyvalent Sales and Forecast by Type (2020-2025)
10.2.2 Global Pneumococcal Vaccine Polyvalent Revenue and Forecast by Type (2020-2025)
10.2.3 Global Pneumococcal Vaccine Polyvalent Price and Forecast by Type (2020-2025)
10.3 China Pneumococcal Vaccine Polyvalent Market Size and Forecast by Type (2015-2025)
10.3.1 China Pneumococcal Vaccine Polyvalent Market Size by Type (2015-2020)
10.3.2 China Pneumococcal Vaccine Polyvalent Market Size and Forecast by Type (2020-2025)
11 Market Segment by Application
11.1 Global Pneumococcal Vaccine Polyvalent Market Size by Application (2015-2020)
11.1.1 Global Pneumococcal Vaccine Polyvalent Sales by Application (2015-2020)
11.1.2 Global Pneumococcal Vaccine Polyvalent Revenue by Application (2015-2020)
11.1.3 Global Pneumococcal Vaccine Polyvalent Price by Application (2015-2020)
11.2 Global Pneumococcal Vaccine Polyvalent Market Size and Forecast by Application (2020-2025)
11.2.1 Global Pneumococcal Vaccine Polyvalent Sales and Forecast by Application (2020-2025)
11.2.2 Global Pneumococcal Vaccine Polyvalent Revenue and Forecast by Application (2020-2025)
11.2.3 Global Pneumococcal Vaccine Polyvalent Price and Forecast by Application (2020-2025)
11.3 China Pneumococcal Vaccine Polyvalent Market Size and Forecast by Application (2015-2025)
11.3.1 China Pneumococcal Vaccine Polyvalent Market Size by Application (2015-2020)
11.3.2 China Pneumococcal Vaccine Polyvalent Market Size and Forecast by Application (2020-2025)
12 Sales Channel, Distributors, Costumers, and Market Dynamics
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Distributors, Traders and Dealers
12.4.1 Market Opportunities
12.4.2 Market Risk
12.4.3 Market Driving Force
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Tables and Figures
List of Tables
Table 1. Global Pneumococcal Vaccine Polyvalent Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Pneumococcal Vaccine Polyvalent by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Pneumococcal Vaccine Polyvalent Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Pneumococcal Vaccine Polyvalent Market Size Overview by Geography (2015-2020) (USD Million)
Table 5. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 6. Merck & Co. Pneumococcal Vaccine Polyvalent Major Business
Table 7. Merck & Co. Pneumococcal Vaccine Polyvalent Total Revenue (USD Million) (2018-2019)
Table 8. Merck & Co. SWOT Analysis
Table 9. Merck & Co. Pneumococcal Vaccine Polyvalent Product and Services
Table 10. Merck & Co. Pneumococcal Vaccine Polyvalent Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 11. Pfizer Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Pneumococcal Vaccine Polyvalent Major Business
Table 13. Pfizer Pneumococcal Vaccine Polyvalent Total Revenue (USD Million) (2018-2019)
Table 14. Pfizer SWOT Analysis
Table 15. Pfizer Pneumococcal Vaccine Polyvalent Product and Services
Table 16. Pfizer Pneumococcal Vaccine Polyvalent Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 17. Global Pneumococcal Vaccine Polyvalent Sales by Manufacturer (2018-2019) (K MT)
Table 18. Global Pneumococcal Vaccine Polyvalent Revenue by Manufacturer (2018-2019) (USD Million)
Table 19. Key Players Pneumococcal Vaccine Polyvalent Sales in China (2018-2019) (K MT)
Table 20. Key Players Pneumococcal Vaccine Polyvalent Sales Market Share in China (2018-2019)
Table 21. Key Players Revenue of Pneumococcal Vaccine Polyvalent in China (2018-2019) (USD Million)
Table 22. Global Pneumococcal Vaccine Polyvalent Sales by Regions (2015-2020) (K MT)
Table 23. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Regions (2015-2020)
Table 24. Global Pneumococcal Vaccine Polyvalent Revenue by Regions (2015-2020) (USD Million)
Table 25. Global Pneumococcal Vaccine Polyvalent Sales and Forecast by Regions (2020-2025) (K MT)
Table 26. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Regions (2020-2025)
Table 27. Global Pneumococcal Vaccine Polyvalent Revenue and Forecast by Regions (2020-2025) (USD Million)
Table 28. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Regions (2020-2025) (USD Million)
Table 29. North America Pneumococcal Vaccine Polyvalent Sales by Countries (2015-2020) (K MT)
Table 30. North America Pneumococcal Vaccine Polyvalent Sales Market Share by Countries (2015-2020)
Table 31. North America Pneumococcal Vaccine Polyvalent Revenue by Countries (2015-2020) (USD Million)
Table 32. North America Pneumococcal Vaccine Polyvalent Revenue Market Share by Countries (2015-2020)
Table 33. North America Pneumococcal Vaccine Polyvalent Sales by Country (2020-2025) (K MT)
Table 34. North America Pneumococcal Vaccine Polyvalent Sales Market Share by Country (2020-2025)
Table 35. North America Pneumococcal Vaccine Polyvalent Revenue by Country (2020-2025) (USD Million)
Table 36. North America Pneumococcal Vaccine Polyvalent Revenue Market Share by Country (2020-2025)
Table 37. Europe Pneumococcal Vaccine Polyvalent Sales by Countries (2015-2020) (K MT)
Table 38. Europe Pneumococcal Vaccine Polyvalent Sales Market Share by Countries (2015-2020)
Table 39. Europe Pneumococcal Vaccine Polyvalent Revenue by Countries (2015-2020) (USD Million)
Table 40. Europe Pneumococcal Vaccine Polyvalent Revenue Market Share by Countries (2015-2020)
Table 41. Europe Pneumococcal Vaccine Polyvalent Sales by Country (2020-2025) (K MT)
Table 42. Europe Pneumococcal Vaccine Polyvalent Sales Market Share by Country (2020-2025)
Table 43. Europe Pneumococcal Vaccine Polyvalent Revenue by Country (2020-2025) (USD Million)
Table 44. Europe Pneumococcal Vaccine Polyvalent Revenue Market Share by Country (2020-2025)
Table 45. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales by Countries (2015-2020) (K MT)
Table 46. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Market Share by Countries (2015-2020)
Table 47. Asia-Pacific Pneumococcal Vaccine Polyvalent Revenue by Countries (2015-2020) (USD Million)
Table 48. Asia-Pacific Pneumococcal Vaccine Polyvalent Revenue Market Share by Countries (2015-2020)
Table 49. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales by Country (2020-2025) (K MT)
Table 50. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Market Share by Country (2020-2025)
Table 51. Asia-Pacific Pneumococcal Vaccine Polyvalent Revenue by Country (2020-2025) (USD Million)
Table 52. Asia-Pacific Pneumococcal Vaccine Polyvalent Revenue Market Share by Country (2020-2025)
Table 53. South America Pneumococcal Vaccine Polyvalent Sales by Countries (2015-2020) (K MT)
Table 54. South America Pneumococcal Vaccine Polyvalent Sales Market Share by Countries (2015-2020)
Table 55. South America Pneumococcal Vaccine Polyvalent Revenue by Countries (2015-2020) (USD Million)
Table 56. South America Pneumococcal Vaccine Polyvalent Revenue Market Share by Countries (2015-2020)
Table 57. South America Pneumococcal Vaccine Polyvalent Sales by Country (2020-2025) (K MT)
Table 58. South America Pneumococcal Vaccine Polyvalent Sales Market Share by Country (2020-2025)
Table 59. South America Pneumococcal Vaccine Polyvalent Revenue by Country (2020-2025) (USD Million)
Table 60. South America Pneumococcal Vaccine Polyvalent Revenue Market Share by Country (2020-2025)
Table 61. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales by Countries (2015-2020) (K MT)
Table 62. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales Market Share by Countries (2015-2020)
Table 63. Middle East & Africa Pneumococcal Vaccine Polyvalent Revenue by Countries (2015-2020) (USD Million)
Table 64. Middle East & Africa Pneumococcal Vaccine Polyvalent Revenue Market Share by Countries (2015-2020)
Table 65. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales by Country (2020-2025) (K MT)
Table 66. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales Market Share by Country (2020-2025)
Table 67. Middle East & Africa Pneumococcal Vaccine Polyvalent Revenue by Country (2020-2025) (USD Million)
Table 68. Middle East & Africa Pneumococcal Vaccine Polyvalent Revenue Market Share by Country (2020-2025)
Table 69. China Pneumococcal Vaccine Polyvalent Sales by Type (2015-2020) (K MT)
Table 70. China Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2015-2020)
Table 71. China Pneumococcal Vaccine Polyvalent Revenue by Type (2015-2020) (USD Million)
Table 72. China Pneumococcal Vaccine Polyvalent Revenue Market Share by Type (2015-2020)
Table 73. China Pneumococcal Vaccine Polyvalent Sales by Type (2020-2025) (K MT)
Table 74. China Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2020-2025)
Table 75. China Pneumococcal Vaccine Polyvalent Revenue by Type (2020-2025) (USD Million)
Table 76. China Pneumococcal Vaccine Polyvalent Revenue Market Share by Type (2020-2025)
Table 77. Global Pneumococcal Vaccine Polyvalent Sales by Application (2015-2020) (K MT)
Table 78. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2015-2020)
Table 79. Global Pneumococcal Vaccine Polyvalent Revenue by Application (2015-2020) (USD Million)
Table 80. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Application (2015-2020)
Table 81. Global Pneumococcal Vaccine Polyvalent Price by Application (2015-2020) (USD/MT)
Table 82. Global Pneumococcal Vaccine Polyvalent Sales by Application (2020-2025) (K MT)
Table 83. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2020-2025)
Table 84. Global Pneumococcal Vaccine Polyvalent Revenue by Application (2020-2025) (USD Million)
Table 85. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Application (2020-2025)
Table 86. Global Pneumococcal Vaccine Polyvalent Price by Application (2020-2025) (USD/MT)
Table 87. China Pneumococcal Vaccine Polyvalent Sales by Application (2015-2020) (K MT)
Table 88. China Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2015-2020)
Table 89. China Pneumococcal Vaccine Polyvalent Revenue by Application (2015-2020) (USD Million)
Table 90. China Pneumococcal Vaccine Polyvalent Revenue Market Share by Application (2015-2020)
Table 91. China Pneumococcal Vaccine Polyvalent Sales by Application (2020-2025) (K MT)
Table 92. China Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2020-2025)
Table 93. China Pneumococcal Vaccine Polyvalent Revenue by Application (2020-2025) (USD Million)
Table 94. China Pneumococcal Vaccine Polyvalent Revenue Market Share by Application (2020-2025)
Table 95. Direct Channel Pros & Cons
Table 96. Indirect Channel Pros & Cons
Table 97. Distributors/Traders/ Dealers List
Table 98. Customers of Pneumococcal Vaccine Polyvalent
Table 99. Market Opportunities in Next Few Years
Table 100. Market Risks Analysis
Table 101. Market Drivers
List of Figures
Figure 1. Pneumococcal Vaccine Polyvalent Picture
Figure 2. Global Pneumococcal Vaccine Polyvalent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. Prevnar 13 Picture
Figure 4. Pneumovax23 Picture
Figure 5. Pneumococcal Vaccine Polyvalent Sales Market Share by Application in 2019
Figure 6. 18 years and younger Picture
Figure 7. 19 to 64 years old Picture
Figure 8. 65 years and older Picture
Figure 9. Global Pneumococcal Vaccine Polyvalent Market Status and Outlook (2015-2025) (USD Million)
Figure 10. Global Pneumococcal Vaccine Polyvalent Sales Growth Rate (2015-2025) (K MT)
Figure 11. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Manufacturer in 2019
Figure 12. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Manufacturer in 2019
Figure 13. Key Players Pneumococcal Vaccine Polyvalent Revenue Market Share in China in 2019
Figure 14. Global Top 5 Pneumococcal Vaccine Polyvalent Manufacturer Market Share in 2019
Figure 15. Top 3 Pneumococcal Vaccine Polyvalent Players Market Share in China in 2019
Figure 16. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Regions in 2019
Figure 17. North America Pneumococcal Vaccine Polyvalent Sales YoY Growth (2015-2025) (K MT)
Figure 18. North America Pneumococcal Vaccine Polyvalent Revenue YoY Growth (2015-2025) (USD Million)
Figure 19. Europe Pneumococcal Vaccine Polyvalent Sales YoY Growth (2015-2020) (K MT)
Figure 20. Europe Pneumococcal Vaccine Polyvalent Revenue YoY Growth (2015-2020) (USD Million)
Figure 21. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales YoY Growth (2015-2020) (K MT)
Figure 22. Asia-Pacific Pneumococcal Vaccine Polyvalent Revenue YoY Growth (2015-2020) (USD Million)
Figure 23. South America Pneumococcal Vaccine Polyvalent Sales YoY Growth (2015-2020) (K MT)
Figure 24. South America Pneumococcal Vaccine Polyvalent Revenue YoY Growth (2015-2020) (USD Million)
Figure 25. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales YoY Growth (2015-2020) (K MT)
Figure 26. Middle East & Africa Pneumococcal Vaccine Polyvalent Revenue YoY Growth (2015-2020) (USD Million)
Figure 27. North America Pneumococcal Vaccine Polyvalent Sales Market Share by Country in 2019
Figure 28. North America Pneumococcal Vaccine Polyvalent Revenue Market Share by Country in 2019
Figure 29. United States Pneumococcal Vaccine Polyvalent Market Size and Growth Rate (2015-2025) (USD Million)
Figure 30. Canada Pneumococcal Vaccine Polyvalent Market Size and Growth Rate (2015-2025) (USD Million)
Figure 31. Mexico Pneumococcal Vaccine Polyvalent Market Size and Growth Rate (2015-2020) (USD Million)
Figure 32. Europe Pneumococcal Vaccine Polyvalent Revenue Market Share by Country in 2019
Figure 33. Germany Pneumococcal Vaccine Polyvalent Market Size Growth Rate (2015-2025) (USD Million)
Figure 34. United Kingdom Pneumococcal Vaccine Polyvalent Market Size Growth Rate (2015-2025) (USD Million)
Figure 35. France Pneumococcal Vaccine Polyvalent Market Size Growth Rate (2015-2025) (USD Million)
Figure 36. Russia Pneumococcal Vaccine Polyvalent Market Size Growth Rate (2015-2025) (USD Million)
Figure 37. Italy Pneumococcal Vaccine Polyvalent Market Size Growth Rate (2015-2025) (USD Million)
Figure 38. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Market Share by Region 2018
Figure 39. Asia-Pacific Pneumococcal Vaccine Polyvalent Revenue Market Share by Region 2018
Figure 40. China Pneumococcal Vaccine Polyvalent Market Size Growth Rate (2015-2025) (USD Million)
Figure 41. Japan Pneumococcal Vaccine Polyvalent Market Size Growth Rate (2015-2025) (USD Million)
Figure 42. Korea Pneumococcal Vaccine Polyvalent Market Size Growth Rate (2015-2025) (USD Million)
Figure 43. India Pneumococcal Vaccine Polyvalent Market Size Growth Rate (2015-2025) (USD Million)
Figure 44. Southeast Asia Pneumococcal Vaccine Polyvalent Market Size Growth Rate (2015-2025) (USD Million)
Figure 45. Australia Pneumococcal Vaccine Polyvalent Market Size Growth Rate (2015-2025) (USD Million)
Figure 46. South America Pneumococcal Vaccine Polyvalent Sales Market Share by Country in 2019
Figure 47. South America Pneumococcal Vaccine Polyvalent Revenue Market Share by Country in 2019
Figure 48. Brazil Pneumococcal Vaccine Polyvalent Market Size Growth Rate (2015-2025) (USD Million)
Figure 49. Argentina Pneumococcal Vaccine Polyvalent Market Size Growth Rate (2015-2025) (USD Million)
Figure 50. Saudi Arabia Pneumococcal Vaccine Polyvalent Market Size Growth Rate (2015-2025) (USD Million)
Figure 51. Turkey Pneumococcal Vaccine Polyvalent Market Size Growth Rate (2015-2025) (USD Million)
Figure 52. Egypt Pneumococcal Vaccine Polyvalent Market Size Growth Rate (2015-2025) (USD Million)
Figure 53. South Africa Pneumococcal Vaccine Polyvalent Market Size Growth Rate (2015-2025) (USD Million)
Figure 54. Global Revenue Market Share of Pneumococcal Vaccine Polyvalent by Type in 2019
Figure 55. Global Revenue Market Share of Pneumococcal Vaccine Polyvalent by Application in 2019
Figure 56. Sales Channel: Direct Channel vs Indirect Channel
Companies Mentioned
Merck & Co.
Pfizer
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets